The Public Health Agency of Canada’s (the Agency’s) Pathogen Regulation Directorate is committed to outreach, engagement and consultation with the public and stakeholders in all aspects of its work. It collaborates with federal partners, provincial and territorial governments, and other interested parties in developing processes that meet specific regulatory and program needs and are flexible enough to respond to changing circumstances and new ideas.
In its most recent five-year Strategic Plan, the Agency committed to change “its approach to stakeholder engagement from a position of consultation and ultimate control to a more inclusive and comprehensive approach to engaging stakeholders as full partners in shaping and delivering results.” The federal government has also formalized core consultation principles for regulations in Guidelines for Effective Regulatory Consultations (Treasury Board Secretariat, 2007). These principles are:
In 2010, the Agency began a process for consulting interested parties in developing the regulatory framework, tools, and regulations under the HPTA. This will continue until 2014.
Draft Biosafety Directive for the Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotropic Virus Type 1(HTLV-1)
The Public Health Agency of Canada has developed a draft Biosafety Directive for HIV and HTLV-1 which provides a comprehensive overview of the updated containment level requirements for laboratories working with HIV and HTLV-1. The draft Biosafety Directive for HIV and HTLV-1 is now available to stakeholders and other interested parties to review and provide input. Please provide your comments to the Agency via email by November 15th, 2013.